Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in targeted therapies in acute myeloid leukemia
Rahul S. Bhansali, Keith W. Pratz, Catherine Lai
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 114

Showing 1-25 of 114 citing articles:

Exosomal circ_0006896 promotes AML progression via interaction with HDAC1 and restriction of antitumor immunity
Can Can, Xinyu Yang, Hexiao Jia, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 11
The clinical features and outcomes of elderly patients with acute myeloid leukemia: a real word research
Xiao Han, Xue Liu, Kai Rui Wan, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Breaking the Bone Marrow Barrier: Peripheral Blood as a Gateway to Measurable Residual Disease Detection in Acute Myelogenous Leukemia
John T. Butler, William M. Yashar, Ronan T. Swords
American Journal of Hematology (2025)
Open Access | Times Cited: 1
Bispecific Aptamer-Drug Conjugates Selectively Eliminate Malignant Hematologic Cells for Treating Acute Myeloid Leukemia
Xiaodong Li, Jiacheng Dai, Yuanyuan Shi, et al.
Langmuir (2025)
Closed Access | Times Cited: 1
Multi-omics advances for molecular characterization, precision medicine, and prognostic implications in leukemia
Shangyu Hou, Junya Liu, Yinghui Zhu
Cell investigation. (2025) Vol. 1, Iss. 1, pp. 100007-100007
Open Access | Times Cited: 1
Targeting a lineage-specific PI3Kɣ–Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader molecule
Loïs Kelly, Justine C. Rutter, Kevin Lin, et al.
Nature Cancer (2024) Vol. 5, Iss. 7, pp. 1082-1101
Closed Access | Times Cited: 7
A novel AML1-ETO/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia
Wei Zhou, Siying Li, Hong Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia
Yuxin Tan, Lilan Xin, Qian Wang, et al.
Cancer Letters (2024) Vol. 592, pp. 216933-216933
Closed Access | Times Cited: 5
Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment
Edoardo Peroni, Maria Luigia Randi, Antonio Rosato, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 14
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Niels Vandewalle, Hatice Satilmis, Emma Verheye, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2656-2674
Open Access | Times Cited: 5
Haploidentical hematopoietic cell transplantation with or without an unrelated cord blood unit for adult acute myeloid leukemia: a multicenter, randomized, open-label, phase 3 trial
Biqi Zhou, Jia Chen, Tianhui Liu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Nanozymes: a new approach for leukemia therapy
Wei Wang, Jingyi An, Runze Zhao, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 10, pp. 2459-2470
Closed Access | Times Cited: 4
Trends in Cancer Incidence and Mortality in US Adolescents and Young Adults, 2016–2021
Li Zhang, Joshua Muscat, Vernon M. Chinchilli, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3153-3153
Open Access | Times Cited: 4
Bone Marrow Endothelial Progenitor Cells remodelling facilitates normal hematopoiesis during Acute Myeloid Leukemia Complete Remission
Tong Xing, Lijuan Hu, Hongyan Zhao, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
HDAC inhibitor enhances ferroptosis susceptibility of AML cells by stimulating iron metabolism
Rui Bian, Yingying Shang, Nahua Xu, et al.
Cellular Signalling (2025) Vol. 127, pp. 111583-111583
Closed Access
Prognostic value of dynamic measurable residual disease monitoring by multi-flowcytometry in elderly patients with non-intensively treated acute myeloid leukemia
Yue Sun, Xiaofeng Han, Yiwei Zhang, et al.
Clinical Lymphoma Myeloma & Leukemia (2025)
Closed Access
PROTAC-Mediated GSPT1 Degradation Impairs the Expression of Fusion Genes in Acute Myeloid Leukemia
Alicia Perzolli, Christian Steinebach, Jan Krönke, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 211-211
Open Access
FT538, iPSC‐derived NK cells, enhance AML cell killing when combined with chemotherapy
Amanda Eckstrom, Anudishi Tyagi, Sajid Mahmood, et al.
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 1
Open Access
Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives
Zahra Khosroabadi, Samaneh Azaryar, Hassan Dianat‐Moghadam, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Synthesis and Anti-acute Myeloid Leukemia Activity of Cyclopropane-1,1-diamide Derivatives Containing Imidazo[1,2-a]pyridine
L. Eduardo Wu, Jiangdong Li, Zhonghua Shi, et al.
Chinese Journal of Organic Chemistry (2025) Vol. 45, Iss. 1, pp. 286-286
Closed Access
HSPG2 could promote normal haematopoiesis in acute myeloid leukaemia patients after complete remission by repairing bone marrow endothelial progenitor cells
Chen‐Yuan Li, Zhenkun Wang, Tong Xing, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 2
Open Access
Pharmacokinetics and ADME Characterization After Oral and Intravenous Administration of [14C]‐Ziftomenib in Healthy Male Participants
Amitava Mitra, Julie Mackey Ahsan, Marilyn Tabachri, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
Proteomic Comparison of Acute Myeloid Leukemia Cells and Normal CD34+ Bone Marrow Cells: Studies of Leukemia Cell Differentiation and Regulation of Iron Metabolism/Ferroptosis
Frode Selheim, Elise Aasebø, Håkon Reikvam, et al.
Proteomes (2025) Vol. 13, Iss. 1, pp. 11-11
Open Access
Treatment of Relapsed/Refractory AML—Novel Treatment Options Including Immunotherapy
Catherine Gutierrez, Anthony S. Stein, Amir T. Fathi, et al.
American Journal of Hematology (2025) Vol. 100, Iss. S2, pp. 23-37
Closed Access
Page 1 - Next Page

Scroll to top